|Packaging Size||1 strip of 10 tablet|
- For the prophylaxis of organ rejection in patients receiving allogeneic renal transplants.
720 mg twice daily Pediatrics :
Based on a pharmacokinetic study conducted in stable renal pediatric transplant patients, the recommended dose in stable pediatric patients is 400 mg/m² body surface area (BSA) administered twice daily (up to a maximum dose of 720 mg administered twice daily). Dosage Adjustment :Renal Impairment :
Not required.Hepatic Impairment :
May be required in renal patients with some hepatic diseases.